Have a personal or library account? Click to login
Case report: exacerbation of hemolytic anemia requiring multiple incompatible RBC transfusions Cover

Case report: exacerbation of hemolytic anemia requiring multiple incompatible RBC transfusions

By: A.M. Svensson,  S. Bushor and  M.K. Fung  
Paid access
|May 2020

References

  1. Issitt PD, Anstee DJ. “Warm” antibody-induced hemolytic anemia (WAIHA). In: Applied blood group serology. 4th ed. Durham, NC: Scientific Publications, 1999:939-93.
  2. Liew YW, Duncan N. Polyethylene glycol in autoadsorption of serum for detection of allo- antibodies (letter). Transfusion l995;35:7l3o
  3. Leger RM, Garratty G. Evaluation of methods for detecting alloantibodies underlying warm autoantibodies. Transfusion 1999;39:11-6.10.1046/j.1537-2995.1999.39199116889.x9920161
  4. Reid ME, Rios M, Powell VI, et al. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion 2OOO;4O:48-53o10.1046/j.1537-2995.2000.40010048.x10644811
  5. Wenk RE, Chiafari FA. DNA typing of recipient blood after massive transfusion. Transfusion 1997; 37:1108-10.10.1046/j.1537-2995.1997.37111298088037.x9426631
  6. Legler TJ, Eber SW, Lakomek M, et al. Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients. Transfusion 1999;39:852-5.10.1046/j.1537-2995.1999.39080852.x10504121
  7. Rozman P, Dov T, Gassner C. Differentiation of autologous ABO, RHD, RHCE, KEL, JK, and FY blood group genotypes by analysis of peripheral blood samples of patients who have recently received multiple transfusions. Transfusion 2000; 40:93642.10.1046/j.1537-2995.2000.40080936.x10960520
  8. Kroll H, Carl B, Santoso S, et al.Workshop report on the genotyping of blood cell alloantigens. Transfus Med 2001;11:211-9.10.1046/j.1365-3148.2001.00307.x11422952
  9. Reid ME, Lomas-Francis C. Molecular approaches to blood group identification. Curr Opin Hematol 2002;9:152-9.10.1097/00062752-200203000-0001211845000
  10. Reid ME, Toy P. Simplified method for recovery of autologous red blood cells from transfused patients. Am J Clin Pathol 1983;79:364-6.10.1093/ajcp/79.3.3646829505
  11. Branch DR, Hian AL, Carlson Ę et al. Erythrocyte age-fractionation using a Percoll-Renografin density gradient: application to autologous red cell antigen determinations in recently transfused patients. Am J Clin Pathol 1983;80:453-8.10.1093/ajcp/80.4.4536312792
  12. Baldwin ML, Barrasso C, Ness PM, Garratty G. A clinically significant erythrocyte antibody detectable only by51Cr survival studies. Transfusion l983;23:4O4.10.1046/j.1537-2995.1983.23183147303.x6402832
  13. Zeiler T, Müller JT, Hasse C, et al. Flow cytometric determination of RBC survival in autoimmune hemolytic anemia. Transfusion 2001;41:493-8.10.1046/j.1537-2995.2001.41040493.x
  14. Mullon J, Giacoppe G, Clagett C, et al. Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. N Engl J Med 2OOO;342:1638-43.10.1056/NEJM200006013422204
  15. Petz LD. Least incompatible units for transfusion in autoimmune hemolytic anemia: should we eliminate this meaningless term? A commentary for clinicians and transfusion medicine professionals. Transfusion 2003;43:1503-7.10.1046/j.1537-2995.2003.00583.x
  16. Ahrens N, Kingreen D, Seltsam A, Salama A. Treatment of refractory autoimmune haemolytic anaemia with anti-CD2O (rituximab). Br J Haematol 2001; 114:244-5.10.1046/j.1365-2141.2001.02873-4.x
  17. Quartier P, Brethon B, Philippet P, et al. Treatment of childhood autoimmune haemolytic anaemia with rituximab. Lancet 2001;358:1511-3.10.1016/S0140-6736(01)06573-4
  18. Morselli M, Luppi M, Potenza L, et al. Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment. Blood 2002;99:3478-9.10.1182/blood-2002-01-001812001903
  19. Silberstein LE, Berkman EM. Plasma exchange in autoimmune hemolytic anemia (AIHA). J Clin Apheresis 1983; 1:238-42.10.1002/jca.29200104076546059
  20. Knezevic-Maramica I, Kruskall MS. Intravenous immune globulins: an update for clinicians. Transfusion 2003;43:1460-80.10.1046/j.1537-2995.2003.00519.x14507280
  21. Wassmuth R, Hauser LA, Schuler K, et al. Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloanti-bodies in vitro. Transplantation 2001 ;7l; 1436-42.10.1097/00007890-200105270-0001411391232
DOI: https://doi.org/10.21307/immunohematology-2019-445 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 177 - 183
Published on: May 16, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 A.M. Svensson, S. Bushor, M.K. Fung, published by American National Red Cross
This work is licensed under the Creative Commons License.